Jiangxi Fushine Pharmaceutical Co (SZSE:300497) Accounts Payable & Accrued Expense : ¥548 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Jiangxi Fushine Pharmaceutical Co Accounts Payable & Accrued Expense?

Jiangxi Fushine Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (¥563 Mil) to Dec. 2024 (¥649 Mil) but then declined from Dec. 2024 (¥649 Mil) to Mar. 2025 (¥548 Mil).

Jiangxi Fushine Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2022 (¥710 Mil) to Dec. 2023 (¥629 Mil) but then increased from Dec. 2023 (¥629 Mil) to Dec. 2024 (¥649 Mil).

Jiangxi Fushine Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jiangxi Fushine Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Fushine Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Jiangxi Fushine Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

503.87

586.27

709.53

629.01

648.74

Jiangxi Fushine Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															572.99	531.21	563.00	648.74	547.66

Jiangxi Fushine Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jiangxi Fushine Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.2 YULI Industrial Zone, Changjiang district, Jiangxi Province, Jingdezhen, CHN, 333000

Website

http://www.fushine.cn

Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.

Executives

Liu Ying	Executives
Peng Yun	Secretary Dong
Zhang Xiang Ming	Executives
Wei Hai Peng	Executives
Bao Jian Hua	Directors, executives
Li Hui Yue	Director
Dai Zhen Liang	Executives
Yang Guang	Executives
Chen Ying Hui	Executives
Ke Dan	Director
Xu Chun Xia	Directors, executives
Yu Wen Jun	Director
Cheng Rong Wu	Directors, executives
Liu Zhi Min	Executives
Tang De Ping	Executives

Jiangxi Fushine Pharmaceutical Co Headlines

No Headlines